Navigation Links
Human Pheromone Sciences Announces Quarterly and Full Year Results
Date:3/31/2008

ar three month period, we believe that focus on these three strategic imperatives will lessen our dependence on the purchasing pattern of one large customer, and ensure balanced growth in revenue and an expanded technology and customer base, without major capital investment," the spokesman further noted.

Human Pheromone Sciences, Inc. is a technology-based company, whose proof-of-concept products included prestige-priced fragrances and toiletries and environmental products sold under the REALM(R), innerREALM(R) and EROX(R) trademarks. These products, and its Natural Attraction(R) product line, contain mood-enhancing synthesized human pheromones covered under U.S. and foreign patents. The Company also licenses its proprietary technology to other companies for inclusion in their products for direct sale to the consumer. Scientific and consumer studies have shown that the Company's human pheromones positively impact on the moods, attitudes and emotions of wearers. Further information is available on line at http://www.erox.com.

The statements in this news release may contain forward-looking statements that involve risks and uncertainties that could cause results to differ from predicted results. Further information on factors that could affect the Company's results is detailed in the Company's annual report to shareholders on Form 10-KSB for the year ended December 31, 2007 as filed with the Securities and Exchange Commission. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements.

HUMAN PHEROMONE SCIENCES, INC.

Condensed Balance Sheets

(Dollars in thousands)

December 31, December 31,

2007 2006

Assets

Cash and cash equivalents
'/>"/>

SOURCE Human Pheromone Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related biology technology :

1. Expiry of Hart-Scott-Rodino Waiting Period for JUVISTA(R) (Human TGF BETA 3)
2. New Initiative Has Shocking Effect: Thousands of Missourians with Abnormal Chromosome Structures Are Not Human
3. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
4. Human Genome Sciences Announces $40 Million Milestone Payment Related to Albuferon(R) Development
5. Novocell Announces Discovery Linking Key Cancer Cell Signaling Pathways With Proliferation and Self-Renewal of Human Embryonic Stem Cells
6. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Thomas Weisel Partners Conference
7. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at BioCentury-Thomson Financial Investment Conference
8. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Bear Stearns Conference
9. Human Pheromone Sciences Enters Into Agreement to Reposition and Promote its Natural Attraction(R) Brand
10. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Merrill Lynch Conference
11. Premier Research Appoints Global Head of Human Resources
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2013)... Lake, MN (PRWEB) June 20, 2013 Over ... trade show displays, has received many questions that can be ... display for me?” Owner of GLM Displays, Matt Lunser, ... describe the differences between his products and offer some useful ... shows and expos. , “This buyer's guide is meant to ...
(Date:6/20/2013)... Belatrix Software, the leading global Nearshore ... its latest initiative – the Belatrix Software Innovation University ... leaders, and business and technology executives to participate in ... of the initiative is to fuel business leaders with ... product innovation efforts. It’s that inspiration that has ...
(Date:6/20/2013)... Sturgeon Bay, WI (PRWEB) June 20, 2013 ... rich in Omega-3 fatty acids, according to Sturgeon ... G Moellendorf, DC, ND, LCP . Recent research ... in increased health and decreased disease. , Researcher Janice ... College of Medicine in Columbus have studied the health ...
(Date:6/20/2013)... Dental decay is the number one chronic disease ... Crisafulli of Crisafulli Dental those statistics are no longer daunting. ... and implemented a cavity prevention program developed by CariFree that ... to 74% . The system is known as ... a solution to dental decay that works,” says Dr. Crisafulli, ...
Breaking Biology Technology:Belatrix Software Kicks off Major Innovation Effort and Invites Innovation Expert to Share How Agile + Design Thinking Accelerate Product Innovation 2Omega-3 Fatty Acids: the Fountain of Youth? 2Omega-3 Fatty Acids: the Fountain of Youth? 3Omega-3 Fatty Acids: the Fountain of Youth? 4Crisafulli Dental Launches Ground Breaking Cavity Prevention Program That Can Lower Decay Rates by 74% 2
... Sigma-Aldrich Corporation,(Nasdaq: SIAL ) will be presenting at ... 25th at 1:00 PM ET in New York. ... the,Internet available at http://ir.sigmaaldrich.com . Users can click ... on, http://ir.sigmaaldrich.com users will need to have Media ...
... ROCKVILLE, Md., Sept. 14 Human Genome,Sciences, Inc. (Nasdaq: ... the,Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference in ... http://www.hgsi.com (Logo: http://www.newscom.com/cgi-bin/prnh/20010612/HGSLOGO ) ... will present,an overview of the company on Tuesday, September ...
... Sept. 14 Palatin,Technologies, Inc. (Amex: PTN ) announced ... 30, 2007. Palatin reported a net loss of,$6.1 million, or ... 30, 2007, compared to a net loss of $7.9 million, ... in 2006. Total revenues in the,quarter ended June 30, 2007 ...
Cached Biology Technology:Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2007 Results; Teleconference and Webcast to be held on September 18, 2007 2Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2007 Results; Teleconference and Webcast to be held on September 18, 2007 3Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2007 Results; Teleconference and Webcast to be held on September 18, 2007 4Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2007 Results; Teleconference and Webcast to be held on September 18, 2007 5Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2007 Results; Teleconference and Webcast to be held on September 18, 2007 6Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2007 Results; Teleconference and Webcast to be held on September 18, 2007 7Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2007 Results; Teleconference and Webcast to be held on September 18, 2007 8
(Date:6/19/2013)... team of researchers at the University of Pittsburgh ... coating of HIV, that could be potential treatments ... generating resistance. These new agents are quite small, ... research was published in the June 2013 issue ... . , The first of many probable applications ...
(Date:6/19/2013)... MedNet Solutions , a global life ... is pleased to announce its participation in the 2013 ... Boston .  This represents the 10 ... cloud-based eClinical solutions, has exhibited at this premier industry ... iMedNet™ EDC , MedNet,s latest, easy-to-use eClinical technology ...
(Date:6/19/2013)... potent physiological anabolic agent for tissue-building and energy ... protein and carbohydrates, and inhibiting their breakdown and ... a major role in stimulating glucose entry into ... removed from the blood following meals. But gaps ... which insulin regulates glucose uptake in fat and ...
Breaking Biology News(10 mins):HIV-derived antibacterial shows promise against drug-resistant bacteria 2MedNet Solutions To Spotlight iMedNet EDC At The 49th DIA Annual Meeting 2Breakthrough research of essential molecule reveals important targets in diabetes and obesity 2
... target muscle may reverse the symptoms of a rare ... mice conducted by medical geneticists at Duke University Medical ... Pompe disease usually die before they reach the age ... targeting corrective genes to muscles may have application in ...
... the flow of water molecules through the brain can help ... if a patient's tumor will shrink, a new study shows. ... developed the assessment, which they call a functional diffusion map. ... diffusion, or movement, of water through the brain and mapped ...
... historic anthropology expedition to Ethiopia's Lake Turkana basin, researchers ... time are roughly 195,000 years old. The researchers ... we all trace to an ancient line that first ... recently as 50,000 years ago. , Ian McDougall of ...
Cached Biology News:Muscle-targeted gene therapy reverses rare muscular dystrophy in mice 2Muscle-targeted gene therapy reverses rare muscular dystrophy in mice 3New imaging method gives early indication if brain cancer therapy is effective, U-M study shows 2New imaging method gives early indication if brain cancer therapy is effective, U-M study shows 3New Clues Add 40,000 Years to Age of Human Species 2New Clues Add 40,000 Years to Age of Human Species 3New Clues Add 40,000 Years to Age of Human Species 4
... particle based purification systems provide high speed ... sample. They offer increased throughput and reproducible ... KingFisher, KingFisher mL and KingFisher 96, covering ... Each system consists of an instrument, specially ...
... PROTECT FROM MOISTURE. AVOID FREEZE/THAW CYCLES. ... cells in vitro by DNA ... their anti-histone-facilitated detection. In this assay, mono- ... binding proteins. Anti-Histone 3 (H3) biotin-labeled antibody ...
... optimized cell lines in combination with ... nucleofection parameters. Nucleofector Kits are only ... Device., Different cell lines can be ... efficiencies and viabilities are given in ...
... solution or in a gel piece, we can ... be digested to produce a mixture of peptides. ... determined by MALDI-TOF, and the amino acid sequences ... will be determined by MALDI-TOF/TOF. The masses and ...
Biology Products: